|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.810 NZD | -.--% |
|
+12.65% | +42.31% |
| 31/07 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 31/07 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 504M 296M 258M 240M 220M 416M 28.28B 422M 2.83B 1.11B 14.08B 1.11B 1.09B 47.21B | P/E 2027 * |
25.6x | P/E 2028 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 534M 314M 273M 254M 233M 440M 29.95B 447M 2.99B 1.17B 14.91B 1.18B 1.15B 50B | EV / Sales 2027 * |
1.76x | EV / Sales 2028 * | 1.53x |
| Free-Float |
22.37% | Yield 2027 * |
0.68% | Yield 2028 * | 0.86% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 19/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 week | +12.65% | ||
| 1 month | +31.42% | ||
| 3 months | +37.43% | ||
| 6 months | +27.59% | ||
| Current year | +42.31% |
| 1 week | 4.22 |  | 4.85 |
| 1 month | 3.67 | | 4.85 |
| Current year | 3.35 | | 4.85 |
| 1 year | 2.54 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
Marree Atkinson
BRD | Director/Board Member | - | 04/09/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 26/6/25 | Free | Founder | 17,755 | 0.0169% | ||
| 2/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +12.65% | +76.84% | +30.00% | 296M | |
| -0.53% | -3.95% | +50.70% | +153.56% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +51.79% | 618B | |
| -2.51% | -3.25% | +28.54% | +68.94% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.69% | -0.30% | +13.76% | +12.83% | 264B | |
| -7.37% | -4.40% | -0.74% | -44.28% | 209B | |
| -0.64% | +2.43% | +29.74% | +65.93% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.77% | 143B | |
| Average | -1.19% | +0.20% | +31.11% | +41.17% | 341.92B | |
| Weighted average by Cap. | -1.00% | -2.01% | +36.15% | +71.90% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 178M 155M 144M 133M 250M 17.03B 254M 1.7B 668M 8.48B 670M 655M 28.43B | 345M 203M 176M 164M 151M 284M 19.35B 289M 1.93B 759M 9.64B 761M 745M 32.31B |
| Net income | 19.7M 11.57M 10.05M 9.36M 8.59M 16.23M 1.1B 16.48M 110M 43.29M 550M 43.44M 42.48M 1.84B | 24.81M 14.57M 12.67M 11.79M 10.82M 20.44M 1.39B 20.76M 139M 54.54M 692M 54.72M 53.52M 2.32B |
| Net Debt | 29.84M 17.52M 15.23M 14.18M 13.02M 24.58M 1.67B 24.96M 167M 65.58M 833M 65.8M 64.35M 2.79B | 24.6M 14.44M 12.56M 11.69M 10.73M 20.26M 1.38B 20.58M 138M 54.07M 686M 54.25M 53.05M 2.3B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | NZD 4.810 | -.--% | 22,546 |
| 30/07/26 | NZD 4.810 | -0.21% | 24,604 |
| 29/07/26 | NZD 4.820 | +7.59% | 58,230 |
| 28/07/26 | NZD 4.480 | +5.16% | 171,664 |
| 27/07/26 | NZD 4.260 | -0.23% | 89,293 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
